ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients-Reference-Cited by-同舟云学术

ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti‐HER2 therapy using transcriptomic data of 3,104 breast cancer patients

Published:2019-05-07 Issue:11 Volume:145 Page:3140-3151
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Fekete János T.¹^ORCID,Győrffy Balázs¹²

Affiliation:

1. 2^nd Department of PediatricsSemmelweis University Budapest Hungary

2. MTA TTK Lendület Cancer Biomarker Research Group, Institute of EnzymologyHungarian Academy of Sciences Budapest Hungary

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32369

Reference38 articles.

1. AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the Use of Biomarkers in Cancer Drug Development: Table 1.

2. Multigene prognostic tests in breast cancer: past, present, future

3. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy

4. Trastuzumab in the Treatment of Breast Cancer

5. Multidrug resistance in cancer: role of ATP–dependent transporters

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic properties of miR-146a-5p from liquid biopsies in prostate cancer: A meta-analysis;Pathology - Research and Practice;2024-10

2. Systematic mapping of mitochondrial calcium uniporter channel (MCUC)-mediated calcium signaling networks;The EMBO Journal;2024-09-11

3. The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer;Cancers;2024-08-31

4. Investigating the impact of the interstitial fluid flow and hypoxia interface on cancer biology using a spheroid-on-chip perfusion system;2024-08-22

5. Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer;Cell Death & Disease;2024-08-20